MotorSignal

The description states that MotorSignal:

• Guides users through two 15-second hand tasks: finger tapping and hand rotation.
• Uses MediaPipe HandLandmarker in the browser for landmark detection.
• Processes motion data using FastAPI backend services with SciPy for analysis.
• Stores session data in MongoDB Atlas Free tier.
• Hosts frontend and API on Vercel.
• Does not upload raw video; only compact world-landmark coordinates are sent to the backend.
• Provides a dashboard showing synthetic history, quality-aware trend views, and clinician summaries.

Inference The product is a browser-based prototype that collects motion data via webcam but keeps raw video local. It aggregates metrics such as repetition rate, amplitude decay, rhythm variability, and capture quality.

The description states:

• MotorSignal was built to explore whether short, repeatable tasks could make subtle movement changes easier to notice over time.
• It avoids asking users to upload sensitive webcam footage.
• The app is described as an exploratory demo, not a diagnostic tool or medical advice.
• It includes safety language and claims about being medically responsible.

Inference The positioning appears to be around privacy-first health data collection and early-stage exploration of motor trend detection. There is no evidence of commercial intent or market traction beyond the hackathon submission.

The description states:

• The app is designed for people who may want to monitor subtle movement changes.
• It includes a dashboard with synthetic history and clinician summary, suggesting potential use by clinicians or researchers.
• It was built as an exploratory demo, not for direct patient-facing use.

Inference The ICP likely includes individuals interested in tracking motor trends, possibly in research or clinical settings. However, no evidence of actual customers or user groups is provided.

The description states:

• MotorSignal is described as an exploratory demo.
• It was built for a hackathon.
• No pricing model or monetization strategy is mentioned.
• The project uses free-tier tools (Vercel, MongoDB Atlas).

Inference There is no evidence of any business model or pricing structure. The product is not presented as a commercial offering.

The description states:

• Built with React and Vite frontend.
• FastAPI backend for analysis.
• Uses MediaPipe HandLandmarker in-browser.
• Raw video stays on device; only landmarks are sent to backend.
• SciPy used for peak detection and metric calculation.
• MongoDB Atlas Free tier stores session data.
• Vercel hosts the frontend and API.
• Codex with GPT-5.6 was used to implement parts of the product.

Inference The technical stack suggests a lightweight, browser-based prototype using open-source tools and AI-assisted development. It is built for demonstration rather than scalability or production use.

The description states:

• MotorSignal is an exploratory demo.
• It was submitted to the OpenAI 2026 hackathon.
• No revenue, customer base, or adoption data are provided.
• The project includes synthetic demo history and is explicitly labeled as not real user data.

Inference There is no evidence of traction, customers, or product maturity beyond a prototype. It is not evident that the product has moved past the demo phase.

The description states:

• MotorSignal explores motion trend detection via browser-based tasks.
• It avoids uploading raw video to address privacy concerns.
• No mention of competitors or market positioning.

Inference There is no evidence of competitive analysis or awareness of existing solutions in this space. The project appears to be self-contained and not part of a known ecosystem.

The description states:

• MotorSignal is an exploratory demo, not a diagnostic tool.
• It does not provide medical advice or diagnosis.
• It was built for a hackathon.
• No clinical validation or regulatory review is mentioned.

Inference The key risk is that the product has no demonstrated real-world utility or clinical validation. It may be perceived as unsafe or untrustworthy if presented outside of its intended demo context.

1. What specific clinical or research use cases are you targeting beyond the demo?
2. Have you validated the task instructions and thresholds with clinicians?
3. Is there any plan to move beyond the demo phase, including regulatory or safety validation?
4. How would you scale this product if it were to be used in a real-world setting?
5. What would be required to transition from a prototype to a commercial offering?